AmeriHealth and Magellan Behavioral
Health, Inc. (Magellan) have developed tools to assist you in monitoring your
patients who are diagnosed with attention deficit/hyperactivity disorder
(ADHD), adult bipolar disorder, depression/suicide, substance-use, and those
who are prescribed atypical, or second-generation, antipsychotics (SGAs).
Updated tip sheets that include
information on ADHD and adult bipolar disorders and pharmacotherapy for
assessing and managing patients with these disorders are available on our
website for all network providers.
Substance-Use Disorders
Identification Overview and Depression/Suicide Overview guides are
also available to all network providers. These guides are double-sided charts
that include information on substance-use disorders and pharmacotherapy for
substance-use disorders, depression treatment, and assessing and managing
suicidal patients.
To assist you in monitoring your
patients who are prescribed SGAs, Magellan has developed a tip sheet and
monitoring log pertaining to SGAs, which briefly describe the benefits, issues,
and side effects of these medications. Magellan also created an informational
tip sheet for member use, Medication Safety and Second-Generation
Antipsychotics, which you may find helpful when treating patients taking
SGAs.
Each of the tip sheets and all the
guides were developed in collaboration with Magellan and provide resources that
support clinical practice guidelines and are consistent with nationally
recognized standards of care.
Go to the Worksheets,
Forms, and Guides page within the Resources for Patient Management
section of our website to review and/or download the tip sheets and guides.
Please call the Provider Supply Line at 1-800-858-4728 to request paper versions.